Tumor suppressor PTEN: Modulator of cell signaling, growth, migration and apoptosis

Journal of Cell Science

Volumn 114, Issue 13, 2001, Pages 2375-2382

  Yamada, K M ^a   Araki, M ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

Adhesion; Anoikis; Cytoskeleton; Integrin; Migration; Tumor suppressor

Indexed keywords

FOCAL ADHESION KINASE; LIPID; MMAC 1 PROTEIN; PHOSPHATASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN SHC; TEP 1 PROTEIN; TYROSINE PHOSPHATASE; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ANOIKIS; APOPTOSIS; ARTICLE; CANCER CELL; CELL ACTIVITY; CELL ADHESION; CELL GROWTH; CELL INVASION; CELL MIGRATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; COORDINATION; CYTOLOGY; DEVELOPMENT; EMBRYO; EMBRYO DEVELOPMENT; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE MUTATION; GENE TARGETING; HUMAN; HUMAN CELL; MODULATION; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

APOPTOSIS; CELL ADHESION; CELL DIVISION; CELL MOVEMENT; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; PHOSPHORIC MONOESTER HYDROLASES; PTEN PHOSPHOHYDROLASE; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

ANIMALIA;

EID: 0034921007     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (85)

1. Mutational spectra of PTEN/MMAC1 gene: A tumor suppressor with lipid phosphatase activity
2. Protein tyrosine phosphatase-PEST regulates focal adhesion disassembly, migration, and cytokinesis in fibroblasts
3. PTEN/MMAC1/TEP1 in signal transduction and tumorigenesis
4. Mutations of the human PTEN gene
5. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway
6. Potential regulation of ADP-ribosylation factor 6 signalling by phosphatidylinositol 3,4,5-trisphosphate
7. Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and induces anoikis
8. Regulation of Akt/PKB activity, cellular growth, and apoptosis in prostate carcinoma cells by MMAC/PTEN
9. The multiple roles of PTEN in tumor suppression
10. Pten is essential for embryonic development and tumour suppression
11. Impaired Fas response and autoimmunity in Pten+/- mice
12. Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse
13. Integrins and anoikis
14. Control of adhesion-dependent cell survival by focal adhesion kinase
15. Transcriptional analysis of the PTEN/MMAC1 pseudogene, ψPTEN
16. The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells
17. Drosophila PTEN regulates cell growth and proliferation through PI3K-dependent and -independent pathways
18. The tumor-suppressor activity of PTEN is regulated by its carboxyl- terminal region
19. Stabilization and productive positioning roles of the C2 domain of PTEN tumor suppressor
20. Expression of the PTEN tumour suppressor protein during human development
21. Restructuring of local adhesion plaques by PI 3-kinase. Regulation by PtdIns(3,4,5)-P(3) binding to alpha-actinin
22. Tumor suppressor PTEN inhibits integrin- and growth factor-mediated mitogen-activated protein (MAP) kinase signaling pathways
23. Shc and FAK differentially regulate cell motility and directionality modulated by PTEN
24. Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC
25. Role of Grb7 targeting to focal contacts and its phosphorylation by focal adhesion kinase in regulation of cell migration
26. Cell cycle arrest by the PTEN tumor suppressor is target cell specific and may require protein phosphatase activity
27. Profiling the downstream genes of tumor suppressor PTEN in lung cancer cells by complementary DNA microarray
28. PTEN affects cell size, cell proliferation and apoptosis during Drosolphila eye development
29. ACAPs are arf6 GTPase-activating proteins that function in the cell periphery
30. Regulation of cell motility by mitogen-activated protein kinase
31. Phosphoinositides determine specificity of the guanine-nucleotide exchange activity of cytohesin-1 for ADP-ribosylation factors derived from a mammalian expression system
32. Absence of PTEN/MMAC1 pseudogene in mice
33. Crystal structure of the PTEN tumor suppressor: Implications for its phosphoinositide phosphatase activity and membrane association
34. Signaling through phosphoinositide 3-kinases: The lipids take centre stage
35. Analysis of the cellular functions of PTEN using catalytic domain and C-terminal mutations: Differential effects of C-terminal deletion on signalling pathways downstream of phosphoinositide 3-kinase
36. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta
37. PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells
38. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer
39. The PTEN/MMAC1 tumor suppressor induces cell death that is rescued by the AKT/protein kinase B oncogene
40. Form, function, and regulation of protein tyrosine phosphatases and their involvement in human diseases
41. Deficiency of Pten accelerates mammary oncogenesis in MMTV-Wnt-1 transgenic mice
42. Genetic deletion of the Pten tumor suppressor gene promotes cell motility by activation of Rac1 and Cdc42 GTPases
43. The PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and induces apoptosis and anoikis in breast cancer cells
44. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate
45. PTEN: A tumour suppressor that functions as a phospholipid phosphatase
46. The PTEN lipid phosphatase domain is not required to inhibit invasion of glioma cells
47. Changes in endometrial PTEN expression throughout the human menstrual cycle
48. P-TEN, the tumor suppressor from human chromosome 10q23, is a dual- specificity phosphatase
49. The lipid phosphatase activity of PTEN is critical for its tumor supressor function
50. Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of PTEN
51. Are there close encounters between signaling pathways?
52. Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors
53. Activation of synovial fibroblasts in rheumatoid arthritis: Lack of expression of the tumour suppressor PTEN at sites of invasive growth and destruction
54. Inhibition of integrin-linked kinase (ILK) suppresses activation of protein kinase B/Akt and induces cell cycle arrest and apoptosis of PTEN-mutant prostate cancer cells
55. Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems
56. Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway
57. The role of phosphoinositide 3-kinase lipid products in cell function
58. Requirement of phosphatidylinositol 3-kinase in focal adhesion kinase- promoted cell migration
59. Alternative splicing of the human PTEN/MMAC1/TEP1 gene
60. Pten: Life as a tumor suppressor
61. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN
62. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers
63. PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5-trisphosphate and Akt/protein kinase B signaling pathway
64. High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice
65. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN
66. PTEN interactions with focal adhesion kinase and suppression of the extracellular matrix-dependent phosphatidylinositol 3-kinase/Akt cell survival pathway
67. Tumor suppressor PTEN inhibition of cell invasion, migration, and growth: Differential involvement of focal adhesion kinase and p130Cas
68. PTEN gene and integrin signaling in cancer
69. 5′ phospholipid phosphatase SHIP-2 causes protein kinase B inactivation and cell cycle arrest in glioblastoma cells
70. Akt/protein kinase B is regulated by autophosphorylation at the hypothetical PDK-2 site
71. From form to function: Signaling by protein tyrosine phosphatases
72. The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus. Implications for PTEN stability to proteasome-mediated degradation
73. The PTEN tumor suppressor protein: An antagonist of phosphoinositide 3- kinase signaling
74. Phosphorylation of the PTEN tail regulates protein stability and function
75. GIT proteins, a novel family of phosphatidylinositol 3,4, 5- trisphophate-stimulated GTPase-activating proteins for ARF6
76. Surfing the p53 network
77. PTEN controls tumor-induced angiogenesis
78. PTEN inhibits insulin-stimulated MEK/MAPK activation and cell growth by blocking IRS-1 phosphorylation and IRS-1/Grb-2/Sos complex formation in a breast cancer model
79. Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression
80. Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2
81. Interaction of the tumor suppressor PTEN/MMAC with a PDZ domain of MAGI3, a novel membrane-associated guanylate kinase
82. PTEN 2, a golgi-associated testis-specific homologue of the PTEN tumor suppressor lipid phosphatase
83. Lipids on the move: Phosphoinositide 3-kinases in leukocyte function
84. Protein-tyrosine phosphatase Shp-2 regulates cell spreading, migration, and focal adhesion
85. Epigenetic PTEN silencing in malignant melanomas without PTEN mutation